nhboy
Ubi bene ibi patria
F.D.A. Criticizes Avastin Use for Breast Cancer
"Genentech’s drug Avastin did not help women with breast cancer live meaningfully longer, and it caused significant side effects, including a few deaths, the Food and Drug Administration said yesterday in a review of the drug.
The analysis by the agency’s staff appeared to dim the prospects that Avastin would win a approval as a treatment for breast cancer. Genentech’s stock fell $2.75, or 3.6 percent, yesterday, closing at $73.50."
http://www.nytimes.com/2007/12/04/business/04avastin.html?_r=1&oref=slogin
"Genentech’s drug Avastin did not help women with breast cancer live meaningfully longer, and it caused significant side effects, including a few deaths, the Food and Drug Administration said yesterday in a review of the drug.
The analysis by the agency’s staff appeared to dim the prospects that Avastin would win a approval as a treatment for breast cancer. Genentech’s stock fell $2.75, or 3.6 percent, yesterday, closing at $73.50."
http://www.nytimes.com/2007/12/04/business/04avastin.html?_r=1&oref=slogin